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Edited by Veli-Pekka LehtoAbstract Hic-5/ARA55 is a LIM-only member of the paxillin
superfamily. Conﬂicting reports have suggested that Hic-5/
ARA55 can both repress and enhance a number of biological pro-
cesses, including myogenesis and tumorigenesis. With two Hic-5
isoforms documented, we hypothesized that multiple Hic-5 iso-
forms may exist that have both overlapping and isoform-speciﬁc
functions. To test this hypothesis, we performed an extensive
analysis of Hic-5 transcripts in both cell lines and mouse tissues
and found 12 distinct isoforms that fall into two sub-families.
These isoforms are derived from both alternative splicing and
alternative transcriptional start sites (TSS). Hic-5 expression
is regulated in a temporally and spatially controlled manner
in vivo. The identiﬁcation of numerous Hic-5 isoforms suggests
that Hic-5 subsumes a number of distinct roles in cells and
may explain the range of biological responses attributed to
Hic-5.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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gland; Focal adhesion; Paxillin1. Introduction
Hic-5, a member of paxillin superfamily, was ﬁrst identiﬁed
as a transforming growth factor beta (TGF-b) or hydrogen
peroxide-inducible cDNA [1,2]. Hic-5 encodes a protein with
three LD and four LIM domains, and shares striking similarity
to paxillin [3]. Hic-5 and paxillin bind to many of the same
proteins [2–7] and both participate in integrin-mediated pro-
cesses [2,5,8,9]. A variety of studies suggest that Hic-5 and pax-
illin share overlapping and antagonistic functions [2,3,8,10,11].
Hic-5 was independently identiﬁed as ARA55, an androgen
receptor co-activator [11] and can serve as a positive activator
for other steroid receptors [11,12]. It is widely expressed in
many cancer cell lines and tumors, suggesting that it may par-
ticipate in carcinogenesis [2,11,13,14]. However, conﬂicting
data shown that Hic-5/ARA55 is induced during cellular senes-
cence and is repressed in immortalized and transformed cells
[1]. Ectopic expression of Hic-5 in immortalized human
ﬁbroblasts induces senescence, suggesting that Hic-5 may have
tumor suppressor and senescence functions [1,2,15].*Corresponding author. Fax: +1 413 545 3243.
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function in myogenesis, where Hu et al. [16] reported that
ectopic Hic-5 blocked diﬀerentiation while Shibanuma et al.
[17] observed a comparable eﬀect with reductions in Hic-5
[16,17].
Two Hic-5 isoforms have been described previously [18] and
designated as Hic-5a and Hic-5b [2]. These two isoforms diﬀer
mainly in that Hic-5a has four LD motifs and Hic-5b three. To
date no comparison of their functions has been performed.
Taken together, we speculated that multiple Hic-5 isoforms
may exist that have both overlapping and isoform-speciﬁc
functions. To test this hypothesis, we examined the expression
of Hic-5 in both C2C12 myoblasts and mouse tissues during
development and homeostasis. Using these cells, we have
cloned and analyzed 12 distinct Hic-5 isoforms that are the
products of both alternative splicing and alternative transcrip-
tion. Furthermore, we show that individual Hic-5 isoforms
have distinct tissue distributions and are developmentally reg-
ulated. We propose that the presence of multiple Hic-5 iso-
forms contributes to complexity of integrin signaling and
may help explain discrepancies in the literature.2. Materials and methods
2.1. Cell culture
C2C12 myoblasts were maintained at 37 C in DMEM (Invitrogen)
with 10% FBS (Atlanta Biologicals) and 10% CO2.
2.2. Western blots
Proteins samples prepared from C2C12 myoblasts were fractionated
by SDS/10% PAGE. Hic-5 proteins were detected with one of three
antisera: one of the two anti-Hic-5 rabbit polyclonal antisera (1:500,
gift of Dr. Thomas or 1:500 [16]) or an anti-Hic-5 mouse monoclonal
antibody (1:2000, BD Biosciences).
2.3. RNA isolation
Total RNA from C2C12 myoblasts was prepared using Qiagen
RNeasy kit following manufactures instructions.
Two-month old BALB/C mice were euthanized and organs rapidly
removed and stored in Qiagen RNAlater reagent until all desired tis-
sues were obtained. The tissues were then minced with scissors and
RNA extracted with the RNeasy kit. In separate experiments, total
RNA from mammary tissues was kindly provided by Dr. Jerrys labo-
ratory. Brieﬂy, mammary tissues were obtained from mature BALB/c
female mice (8–10 weeks) that were nulliparous (virgin), mid-preg-
nancy (15 days) or undergoing involution following forced-weaning
of pups at 5 days of lactation (weaning 2, 5 or 14 days)[19,20]. RNA
was isolated using Ultraspec and RNA Tack Resin following the
manufacturers protocol (Biotecx Laboratories).ation of European Biochemical Societies.
Table 1
Primers for RT-PCR and QPCR
Primersa Sequence
PCR
93S TAC TCT CCC CAA GCT GTC
572S TCC TCA GGG CAA GAA AGA GA
928S TGG GTG TCA AAC ATA CAG CC
1148S CCT TGG TCT GAC CCT GTG A
1238S ACT CTA ACC TCT TAA GAC C
1275AS CCT CAG GGT GAG AGT TTG
1288AS TGT GGT GAG AGG CCC TCA
1459AS TAC TGT GCT GTA TAG ATG ATC CTT
1765AS GGC CAT CAG TCT ATC CAG
QPCR
92S CTA CTC TCC CCA AGC TGT C
1218S GGA CAC TTG AAA TCC TTT ATA CTC T
1459AS TAC TGT GCT GTA TAG ATG ATC CTT
aPrimers were named after the number of the ﬁrst (last) nucleotide of
the sense (antisense) primers in a Hic-5 cDNA clone (accession number
BC056362).
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Hic-5 isoform-speciﬁc primers were used to amplify cDNA (see Ta-
ble 1 and Section 3). The primer and nucleotide (Nt.) numbers used are
based on the original Hic-5 cDNA clone (Genebank Accession No.
BC056362). Aliquots of 2–4 lg RNA were used for reverse transcrip-
tion (RT) with random hexamers following the Sigma Co. Enhanced
Avian First Strand Synthesis Kit protocol. Brieﬂy, the RT mixture
was incubated at 25 C 15 min, 42 C for 40 min, 50 C for 15 min
and 95 C for 5 min followed by storage at 4 C or PCR. 1–2 ll of
RT material was used for PCR with Qiagen HotStar Taq at: 95 C
for 15 min, 30 cycles of 94 C for 30 s, 55–56 C for 45 s, 72 C 1–
2 min followed by a 10 min extension after the last cycle. PCR prod-
ucts were cloned into pCR2.1 TOPO vector (Invitrogen) and se-
quenced (Davis Sequencing). GAPDH was used as control.
Quantitative PCR (QPCR) was performed in 50 ll/reaction using an
Mx4000 QPCR System (Stratagene) and Brilliant SYBR Green
QPCR Master Mix at 95 C for 10 min, 40 cycles of 95 C for 30 s,
56 C for 50 s, 72 C for 60 s followed with melting curve analysis.
GAPDH was used as control.3. Results
3.1. Identiﬁcation of Hic-5 isoforms
We performed Western blot analysis of proteins from C2C12
myoblasts using three diﬀerent anti-Hic-5 antibodies. Indepen-
dent of the antibody employed, we consistently observed sev-
eral wide bands between 40 and 60 kDa (Fig. 1A and data
not shown). This agrees with published Hic-5 Western blots
[3–5,7], suggesting the presence of multiple Hic-5 proteins
and/or post-translational modiﬁcations.Fig. 1. Identiﬁcation of multiple Hic-5 isoforms in C2C12 myoblasts and mo
C2C12 myoblasts. (B) RT-PCR analysis was performed with mRNA from m
1765AS) and b (1238S and 1765AS). Data from mouse ovary mRNA is shoIn the absence of isoform-speciﬁc antisera we cannot deter-
mine the identities of these diﬀerent proteins, but based on
molecular weight the pair in the middle of the blot (denoted
with asterisks) presumably correspond to Hic-5a and b. We
performed RT-PCR to determine if multiple Hic-5 mRNAs
could be isolated. Hic-5a and Hic-5b mRNAs diﬀer in their
5 0 UTR, so primers were designed that could discriminate
them (Table 1). Then RT-PCR was performed with mRNA
from C2C12 cells or mouse tissues and the products were sub-
cloned and sequenced. A range of products were generated
with each set of primers (Fig. 1B). In total 12 mRNAs were
identiﬁed: 5 with Hic-5a and 7 with Hic-5b. The two most
prominent bands correspond in size to Hic-5a and Hic-5b
[2,18]. Following the precedent of integrin nomenclature, we
named the novel isoforms, respectively, as Hic-5a-B, C, D, E
and Hic-5b-B, C, D, E, F, G (Gene bank Accession No.
DQ143891–DQ143900). Each of these transcripts was concep-
tually translated. Several of them have diﬀerent 5 0 UTRs but
encode same proteins: Hic-5b-B and D encode the same 350
amino acids (aa) protein while Hic-5b-E and F encode a pro-
tein with 399aa. In total, the 12 transcripts encode 10 diﬀerent
proteins (Table 2 and Fig. 2).
3.2. Genetic basis for Hic-5 isoform diversity
Several mechanisms could account for Hic-5 isoform diver-
sity: gene duplication, alternative splicing and alternative tran-
scription. Gene duplication seems unlikely since no nucleotide
or amino acids substitutions were observed among the con-
served coding regions (Fig. 2 and data not shown).
To evaluate the possibility of alternative splicing, we com-
pared each of the Hic-5 variants to the Hic-5 genomic sequence
(accession number AF083064). The isoforms fell into two dis-
tinct classes: the Hic-5a group with exon 1 0 and the Hic-5b
group which lacks exon 1 0 (Table 2). The Hic-5a group mainly
exploits exon skipping to generate distinct isoforms while b
uses intron retention [21].
Since Hic-5a contains exon 1 0 and Hic-5b starts with exon 1,
we speculated that the two families initiate transcription from
diﬀerent promoters. The pre-mRNA of Hic-5a group appears
to initiate upstream Nt. 126, while that of Hic-5b starts down-
stream of Nt. 126 (see Fig. 3). If this is correct, we should not
be able to amplify cDNA sequences with primers that include
Hic-5b speciﬁc sequences (Nt.1148-1306) and those upstream
of Nt. 126. Consequently, we used a series of primer pairs to
determine if Hic-5b transcripts have the sequences derived
from the genome 5 0. Genomic DNA was used as a control
for all primer pairs (Fig. 3B lanes 1–4 and data not shown,
Fig. 3C lanes 9–11). All primer pairs downstream of Nt.use organs. (A) Hic-5 Western blots analysis of proteins isolated from
ouse organs and C2C12 myoblasts using primers for Hic-5a (93S and
wn here.
Table 2
Hic-5 mRNAs and proteins
Name mRNA Protein
a All 11 exons 461aa with LD1–LD4
-B 10 Exons, missing exon 1 460aa with LD2–LD4
-C 10 Exons, missing exon 3 376aa with LD3–LD4
-D 10 Exons, missing exon 1 and Nt4-32 of Exon 5 351aa with LD3–LD4
-E 10 Exons, missing exon 3 but with 5 bp of TACAG insertion between exon 2 and exon 4. 415aa with LD1, LD3–LD4
b 10 Exons, missing exon 10 444aa with LD2–LD4
-B 10 Exons, missing exon 10 but with intron between exon 1 and 2 350aa with LD3–LD4
-C 10 Exons, missing exon 10 and the ﬁrst 18 nts of exon 4 but with the intron between exon 2 and 3 355aa with LD3–LD4
-D 10 Exons, missing exon 10 but with the intron between exon 3 and 4 350aa with LD3–LD4
-E 10 Exons, missing exon 10 but with intron between exon 4 and 5 399aa with LD3–LD4
-F 10 Exons, missing exon 10 but with the introns between exon 1 and 2, exon 4 and 5 399aa with LD3–LD4
-G 10 Exons, missing exon 10 and the ﬁrst 64 nts of exon 3 402aa with LD2–LD4
Fig. 2. Hic-5 protein alignment and analysis. (A) Conceptual translation and alignment of Hic-5 isoforms. LD motifs are underlined, the single
known tyrosine phosphorylation site is in bold and all potential serine and threonine phosphorylation sites are marked with stars. Sequences not
shown are identical for all isoforms. (B) Representation of the inferred protein structures for Hic-5 isoforms. LD: leucine-rich LD motifs (consensus
LDXLLXXL), the C-terminal LIM domains are represented by solid lines and shared by all isoforms. Y: potential tyrosine phosphorylation site.
Hic-5b-B and b-D encode a same protein of 350aa and Hic-5b-E and F encode one of 399aa but have diﬀerent 5 0 UTRs.
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and data not shown, Fig. 3C lane 12) while none were gener-
ated with primers upstream of Nt. 1148 (Fig. 3B lanes 7 and
8 and data not shown; Fig. 3C lanes 13 and 14). These data
are consistent with the hypothesis that Hic-5b is not tran-
scribed from the same promoter as Hic-5a. Instead it appears
that Hic-5b relies on a putative promoter between Nt. 126 and
1148. Accordingly, a schematic representation of genomic
organization of Hic-5 gene and transcripts is depicted
(Fig. 4). The identities of the minor bands in Fig. 3C lanes
13 and 14 are unknown and may represent non-speciﬁc ampli-
ﬁcation or additional splicing events between upstream of Nt.
126 and downstream of Nt. 1148.
Additionally, we conducted promoter-reporter assays but
unfortunately none of the presumptive Hic-5b promoter con-
structs or deletions displayed substantially greater activity thanthe control vector. This could mean that: (1) the 5 0 region of
Hic-5b lacks transcriptional activity; (2) it is a weak promoter;
(3) we failed to identify appropriate conditions for its activa-
tion.
3.3. Hic-5 isoform expression diﬀers among tissues
To determine if Hic-5 isoforms are diﬀerentially expressed
in vivo, we performed RT-PCR on RNA from mouse tissues
(Fig. 5). Each of the Hic-5a transcripts was abundantly ex-
pressed in all tissues examined, with the exception of the ner-
vous system which predominantly expressed the smallest
isoform(s). Lung, ovary and mammary gland had the highest
overall levels of Hic-5a mRNAs.
Hic-5b transcripts were much less abundant than Hic-5a
group. Lung and ovary had the highest while brain again dis-
played the lowest. A very high molecular weight Hic-5b group
Fig. 3. PCR analysis of Hic-5 transcripts and genomic DNA to evaluate alternative transcription. (A) Schematic representation of Hic-5 genomic
organization (up to exon 2). Primer pairs were selected that would deﬁne the 5 0 UTRs of Hic-5a and b, and the intron region between exon 1 0 (Nt.
126) and exon 1 (Nt. 1148). The shaded boxes reﬂect exons and the intervening lines spliced introns. The block arrows represent the presumptive Hic-
5a and Hic-5b TSSs, and the two arrowheads denote, respectively, Nt. 126, the start codon of Hic-5a and Nt. 1148, the 5 0-end of the published Hic-
5b. Arrows represent primers: 1459AS for a and b, 93S for Hic-5a UTR, 572S and 978S for the intron between Exon 1 0 and Exon 1, the rest for b
UTR. (B) PCR analysis was performed with genomic DNA that includes the Hic-5 locus and RT-PCR with mRNA isolated from C2C12 cells. All
primer pairs generated proper products with genomic DNA (lanes 1–4). With C2C12 cDNA, both primer pairs (1148S or 1238S with 1459AS; lanes 5
and 6) targeting for known Hic-5b sequences succeeded while both experimental primer pairs (572S or 978S with 1459AS; lanes 7 and 8) targeting
hypothetical transcribed sequence between Nt. 126 and 1148 failed. Four more pairs of primers were tested to conﬁrm the above results (data not
shown). Therefore, Hic-5bmRNA cannot be produced using Hic-5a promoter without splicing.M, molecular weight. (C) All primers pairs succeeded
with genomic DNA (lanes 9–11). With cDNA, primer pairs (1148S with 1288AS, lane 12) targeting for known Hic-5b sequence succeeded while both
(93s with 1288AS or 1275AS) primer pairs designed to detect the potential splicing events between Nt. 126 and 1148 failed, suggesting that no splicing
events take place between Nt. 126 and 1148. The identities of the smaller bands in lanes 13 and 14 are unknown. Taken together, we reach a tentative
conclusion that Hic-5b transcribes from an alternative promoter.
Fig. 4. Genomic organization and alternative splicing of Hic-5 gene. Intron/exon analysis of the Hic-5 transcripts (up to exon 6). The shaded boxes
reﬂect distinct exons, the intervening lines spliced introns and the block arrows TSS.
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Fig. 5. Tissue distribution of Hic-5 isoforms. RT-PCR was employed to amplify Hic-5 isoforms from RNA derived from mouse organs. M: DNA
ladder; lanes: 1, brain; 2, mammary gland (MG); 3, colon; 4, heart; 5, kidney; 6, liver; 7, lung; 8, testis; 9, spleen; 10, thymus; and 11, ovary. Primers
are the same as described for Fig. 1.
Fig. 6. Developmental regulation of Hic-5 isoforms in mammary gland. QPCR was used to determine the relative expression of Hic-5a and Hic-5b
transcripts from mouse mammary glands isolated at diﬀerent stages of post-natal development. GAPDH was used to normalize the analysis.
Z. Gao, L.M. Schwartz / FEBS Letters 579 (2005) 5651–5657 5655product was expressed uniquely in spleen and thymus. We se-
quenced it and found that it encoded non-spliced Hic-5b pre-
mRNA or genome contamination (data not shown). Given
the extensive apoptosis that occurs in lymphatic tissue at this
stage of development, these sequences could reﬂect contami-
nating fragments of apoptotic DNA.
3.4. Expression of Hic-5 isoforms is developmentally regulated
in the mammary gland
The data presented above demonstrate that Hic-5 expression
is regulated in a tissue-speciﬁc manner. To determine if it is
developmentally regulated as well, we examined the mammary
gland since it undergoes profound changes in response to hor-
mones and growth factors during pregnancy [19,20,22]. UsingQPCR we determined the relative abundance of the Hic-5a
and Hic-5b family transcripts in virgin animals and through-
out pregnancy and weaning (Fig. 6). As with the tissue distri-
bution data, Hic-5a transcripts were more abundant than
Hic-5b at all stages examined. Relative to virgins, Hic-5 was
reduced dramatically during pregnancy and then induced sig-
niﬁcantly at the later stages of weaning.4. Discussion
Hic-5 has been shown to play key roles in various processes,
including: apoptosis, tumorigenesis, myogenesis, hormone
action, integrin signaling and neurotransmitter release
5656 Z. Gao, L.M. Schwartz / FEBS Letters 579 (2005) 5651–5657[1,2,9,11,12,16,23,24]. While two distinct isoforms (a and b)
were described in the literature [2,18], no studies have speciﬁ-
cally examined their respective roles in biological processes.
Such an analysis is essential if we are to dissect Hic-5/
ARA55 action and interpret data from diﬀerent laboratories.
Support for this contention comes from an analysis of myo-
genesis where Hic-5b inhibits myoblast fusion while Hic-5a is
permissive (Gao and Schwartz, in preparation).
The current study demonstrates that Hic-5 expression is reg-
ulated in a temporally and spatially controlled manner in vivo.
Curiously, despite the complexity of the brain, there are only a
few Hic-5 isoforms while a more homogeneous tissue such as
lung has many. Even within a single tissue such as the mam-
mary gland, Hic-5 expression changes dramatically with devel-
opment: 10 fold for Hic-5a group and 50 fold for Hic-5b
group. Consistent with studies suggesting that Hic-5 inhibits
proliferation [1,15,25], Hic-5 expression is low through the ac-
tive period of proliferation during pregnancy. During later
stage of weaning, when the mammary gland undergoes hor-
monal change induced involution, Hic-5 level is at its highest.
In addition to Hic-5a and b, we have cloned and analyzed an
additional ten forms, of which three (Hic-5a-B, C and E) were
conﬁrmed via mouse EST database analysis (data not shown).
At present we cannot exclude the possibility that some of these
isoforms were resulted from aberrant or incomplete splicing,
since they havent been conﬁrmed individually at protein level.
However, the tissue speciﬁc and developmentally regulated
expression of these novel transcripts strongly suggests that
they represent authentic transcripts that may regulate speciﬁc
cellular processes. It is worth noting that our analysis was
not exhaustive and more Hic-5 isoforms may be expressed.
Additionally, the Hic-5a-B transcript we describe carries one
more G than the genomic sequence deposited in Genbank,
which would result in a 488aa protein and diﬀer slightly at
the N-terminus from the 460aa one we describe (Fig. 2 and
Table 2).
Our analysis suggests that the two Hic-5 sub-families utilize
diﬀerent promoters and therefore likely respond to diﬀerent
transcriptional regulation. One Hic-5b variant has been depos-
ited in Genbank (Accession No. BC056362) that contains the
sequence between Nt. 126 and 1148 (Fig. 3), suggesting that
it too can be transcribed from Hic-5a promoter. Although this
raises a caution for our alternative transcription analysis, it
does not preclude the possibility that Hic-5a and b initiate at
alternative TSS. Indeed, even transcripts that encode identical
proteins can utilize diﬀerent promoters and initiate at diﬀerent
TSS, which likely plays important roles in temporal or spatial
control of expression [26,27].
All the Hic-5 isoforms identiﬁed are identical within the
LIM domains, which serve to target Hic-5 and paxillin to focal
adhesions, as well as mediate hormone co-activation [2,10,11].
This implies that all the isoforms identiﬁed here are likely to
retain the capacity to target focal adhesions and to function
as hormonal co-regulators, an assumption that awaits experi-
mental testing.
In contrast, these Hic-5/ARA55 isoforms diﬀer at their N-
termini. For example, Hic-5a contains four LD motifs that
are homologous to those found in paxillin and may bind many
of the same proteins, including: FAK [7], integrin [28], integrin
linked kinase (ILK) [29] and bovine papilloma virus type 1 E6
(BE6) [30]. Loss of LD1, observed in Hic-5a-B, Hic-5b, and
Hic-5b-G, would abolish their ability to interact with ILKand EB6, but not necessarily FAK or integrin. Hic-5a-E pos-
sesses LD1 but lacks LD2, and therefore presumably still binds
to ILK and BE6, but perhaps not FAK. The rest of the Hic-5
isoforms lack LD1-2, which likely prevents their binding to
ILK, EB6, integrin, and FAK. The LD1 of paxillin is impor-
tant for BE6-mediated cell transformation [31,32], suggesting
that Hic-5a and b can exert diﬀerent roles in BE6-dependent
cell transformation and may help explain the discrepancies
regarding ARA55 function in tumorigenesis [2].
As well, Hic-5 isoforms carry diﬀerent compliments of
putative phosphorylation sites such as the tyrosine 60 (Y60)
residue, which plays a key role in ARA55s ability to
function as an androgen receptor co-activator [33]. Only three
(Hic-5a, Hic-5a-B and Hic-5b) of the 12 Hic-5 isoforms con-
tain Y60.
Adding to the complexity of Hic-5 action is its ability to
homo and/or hetero-dimerize [34]. With 12 transcripts that en-
code 10 distinct proteins, theoretically 55 dimers could be pro-
duced, each with distinct properties and contribute to the
complexity of integrin signaling network and diverse hormonal
actions together with other paxillin superfamily members.
This report raises several key issues. First, with 12 isoforms,
multiple phosphorylation sites and the ability to dimerize, Hic-
5/ARA55 regulation of cellular signaling is vastly more com-
plicated than previously assumed. Second, caution needs to
be taken when deﬁning roles for Hic-5/ARA55 unless the iden-
tities of the relevant isoforms have been determined. Third, our
study and unpublished data suggest more paxillin superfamily
members exist.
It will be valuable to determine which Hic-5 isoforms com-
pete with and which may antagonize paxillin-dependent signal-
ing. These insights will greatly enhance our understanding of
not only integrin signaling but also of major developmental
and/or pathological changes such as myogenesis, mammary
gland involution and tumorigenesis.
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